Cargando…
P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430574/ http://dx.doi.org/10.1097/01.HS9.0000846732.06415.be |
| _version_ | 1784779809160691712 |
|---|---|
| author | Vaxman, I. Kumar, S. buadi, F. Lacy, M. Dingli, D. Fonder, A. Hobbs, M. Hayman, S. hwa, L. Y. Kouralis, T. Warsame, R. Muchtar, E. Nelson, L. Kapoor, P. Grogan, M. Go, R. Gonsalves, W. Siddiqi, M. Robert, K. Rajkumar, V. Gertz, M. Dispenzieri, A. |
| author_facet | Vaxman, I. Kumar, S. buadi, F. Lacy, M. Dingli, D. Fonder, A. Hobbs, M. Hayman, S. hwa, L. Y. Kouralis, T. Warsame, R. Muchtar, E. Nelson, L. Kapoor, P. Grogan, M. Go, R. Gonsalves, W. Siddiqi, M. Robert, K. Rajkumar, V. Gertz, M. Dispenzieri, A. |
| author_sort | Vaxman, I. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430574 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94305742022-08-31 P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE Vaxman, I. Kumar, S. buadi, F. Lacy, M. Dingli, D. Fonder, A. Hobbs, M. Hayman, S. hwa, L. Y. Kouralis, T. Warsame, R. Muchtar, E. Nelson, L. Kapoor, P. Grogan, M. Go, R. Gonsalves, W. Siddiqi, M. Robert, K. Rajkumar, V. Gertz, M. Dispenzieri, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430574/ http://dx.doi.org/10.1097/01.HS9.0000846732.06415.be Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Vaxman, I. Kumar, S. buadi, F. Lacy, M. Dingli, D. Fonder, A. Hobbs, M. Hayman, S. hwa, L. Y. Kouralis, T. Warsame, R. Muchtar, E. Nelson, L. Kapoor, P. Grogan, M. Go, R. Gonsalves, W. Siddiqi, M. Robert, K. Rajkumar, V. Gertz, M. Dispenzieri, A. P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE |
| title | P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE |
| title_full | P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE |
| title_fullStr | P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE |
| title_full_unstemmed | P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE |
| title_short | P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE |
| title_sort | p966: daratumumab, carfilzomib, pomalidomide and elotuzumab for the treatment of poems syndrome- the mayo clinic experience |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430574/ http://dx.doi.org/10.1097/01.HS9.0000846732.06415.be |
| work_keys_str_mv | AT vaxmani p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT kumars p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT buadif p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT lacym p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT dinglid p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT fondera p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT hobbsm p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT haymans p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT hwaly p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT kouralist p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT warsamer p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT muchtare p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT nelsonl p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT kapoorp p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT groganm p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT gor p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT gonsalvesw p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT siddiqim p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT robertk p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT rajkumarv p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT gertzm p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience AT dispenzieria p966daratumumabcarfilzomibpomalidomideandelotuzumabforthetreatmentofpoemssyndromethemayoclinicexperience |